Cargando…
Loss of interferon regulatory factor 5 (IRF5) expression in human ductal carcinoma correlates with disease stage and contributes to metastasis
INTRODUCTION: New signaling pathways of the interleukin (IL) family, interferons (IFN) and interferon regulatory factors (IRF) have recently been found within tumor microenvironments and in metastatic sites. Some of these cytokines stimulate while others inhibit breast cancer proliferation and/or in...
Autores principales: | Bi, Xiaohui, Hameed, Meera, Mirani, Neena, Pimenta, Erica Maria, Anari, Jason, Barnes, Betsy J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3326553/ https://www.ncbi.nlm.nih.gov/pubmed/22053985 http://dx.doi.org/10.1186/bcr3053 |
Ejemplares similares
-
Specific detection of interferon regulatory factor 5 (IRF5): A case of antibody inequality
por: Li, Dan, et al.
Publicado: (2016) -
TRIpartite Motif 21 (TRIM21) Differentially Regulates the Stability of Interferon Regulatory Factor 5 (IRF5) Isoforms
por: Lazzari, Elisa, et al.
Publicado: (2014) -
A conserved region within interferon regulatory factor 5 controls breast cancer cell migration through a cytoplasmic and transcription-independent mechanism
por: Pimenta, Erica Maria, et al.
Publicado: (2015) -
Potential T Cell-Intrinsic Regulatory Roles for IRF5 via Cytokine Modulation in T Helper Subset Differentiation and Function
por: Brune, Zarina, et al.
Publicado: (2020) -
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations
por: Kristjansdottir, G, et al.
Publicado: (2008)